Oncology providers’ perspectives on endocrine therapy prescribing and management

PURPOSE: Adjuvant endocrine therapy (ET) can reduce the risk of recurrence among females with hormone receptor-positive breast cancer. Overall, initiation and adherence to ET are suboptimal, though reasons are not well described. The study’s objective was to better understand ET decision making, pre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Patient Prefer Adherence
Autors principals: Wheeler, Stephanie B, Roberts, Megan C, Bloom, Diane, Reeder-Hayes, Katherine E, Espada, Maya, Peppercorn, Jeffrey, Golin, Carol E, Earp, Jo Anne
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5053382/
https://ncbi.nlm.nih.gov/pubmed/27757021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S95594
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars